TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Bill Slattery
Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Ocular Therapeutix granted inducement equity awards to a new non-executive employee, consisting of a stock option and restricted stock unit award. The company continues to develop its retinal disease treatment pipeline, with AXPAXLI in Phase 3 clinical trials for wet age-related macular degeneration.

Insights
JPMpJ   positive

Highlighted as an example of a reliable, long-term investment stock


OCUL   positive

Company is progressing clinical trials, expanding its product pipeline, and making strategic employee equity grants, indicating ongoing growth and development